PET/CT fused image with anatomical and functional information have improved medical diagnosis and interpretation. This fusion has resulted in more precise localization and characterization of sites of radio-tracer uptake. However, a motion during whole-body imaging has been recognized as a source of image quality degradation and reduced the quantitative accuracy of PET/CT study. The respiratory motion problem is more challenging in combined PET/CT imaging. In combined PET/CT, CT is used to localize tumors and to correct for attenuation in the PET images. An accurate spatial registration of PET and CT image sets is a prerequisite for accurate diagnosis and SUV measurement. Correcting for the spatial mismatch caused by motion represents a particular challenge for the requisite registration accuracy as a result of differences in PET/CT image. This paper provides a brief summary of the materials and methods involved in multiple investigations of the correction for respiratory motion in PET/CT imaging, with the goal of improving image quality and quantitative accuracy.
Positron-Emission Tomography and Computed Tomography

No abstract available.
Positron-Emission Tomography and Computed Tomography*

No abstract available.
Positron-Emission Tomography and Computed Tomography*

Positron Emission tomography Response Criteria In Solid Tumors (PERCIST) version 1.0 was introduced in 2009 for objective assessment of tumor metabolic response using ¹⁸F-FDG PET/CT. Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0 was published in 2016 to review and clarify some of the issues with the PERCIST. In this article, we reflect on the benefits and challenges of implementing PERCIST, and speculate on topics that could be discussed in PERCIST 1.1 in the future.
Positron-Emission Tomography ; Positron-Emission Tomography and Computed Tomography

Study on adults patients who were multislice computed tomography of craniofacial at the Post and Telecommunication N02 hospital from January to June 2005. In 51 cases there were 22 males and 29 females, age from 22-56 years. 102 sinuses were studied. Results: the diameters of sphenoidal sinus were measured by the greatest diameter with 3 Sagittal Coronol and Axial planes. The general size of sphenoidal sinus: horizontal diameter 1.932 cm, anterio-posterio diameter 2.347 cm, superio-posterio diameter 2.483 cm, superior-inferior diameter 3.156 cm, capacity 3.727 cm3. The technique of multislice computed tomography was the basis and necessary technique not only for diagnosis but also for the base of services in treatment.
Sphenoid Sinusitis ; Tomography ; Tomography, X-Ray Computed

No abstract available.
Nephritis* ; Positron-Emission Tomography and Computed Tomography* ; Succimer*

Background: Non-specific focal uptake in the skeleton is a diagnostic pitfall on 18F-PSMA-1007 PET/CT, but adjunctive measures to aid interpretation of these lesions are currently lacking. We present two cases where dual time point imaging provided additional information. Case Presentation: The first patient had a PI-RADS 3 lesion on MRI. No PSMA-avid abnormality was seen on PET, save for focal uptake in the right pubis with no anatomic correlate. Additional imaging showed a decrease in lesion SUV, and this was interpreted as benign. Another patient, diagnosed with prostate cancer, had multiple PSMA-avid pelvic foci. Two suspiciously malignant bone lesions had increasing SUV trend after dual time point imaging despite only faint sclerosis on CT. In contrast, one faint PSMA-avid lesion with no anatomic abnormality was read as benign after a decrease in SUV. A decrease in lesion SUV may point to a benign etiology, while an increase would heighten suspicion for malignancy. One possible molecular explanation is that a true PSMA-overexpressing lesion would bind to the tracer for a longer period than a false positive. Conclusion Dual time point imaging provides additional information that may be useful in the interpretation of non-specificskeletal lesions with increased 18F-PSMA-1007 uptake.
PSMA-1007 ; Positron Emission Tomography Computed Tomography

No abstract available.
Electrons* ; Positron-Emission Tomography*

PET/CT is a new imaging technology that combines high-quality Positron Emission Tomography (PET) and Computed Tomography (CT). This imaging provides simultaneous anatomical and metabolic information. Therefore PET/CT is useful diagnostic modality for early detection of malignant tumor, accurate staging, decision on therapeutic plan, monitoring response to therapy and rapid detection of recurrence. We report oral and maxillofacial cancers diagnosed by using PET/CT and the usefulness of PET/CT in the evaluation of postoperative recurrence.
Mouth Neoplasms* ; Positron-Emission Tomography ; Positron-Emission Tomography and Computed Tomography* ; Recurrence ; Tomography, X-Ray Computed

No abstract available.
Electrons* ; Positron-Emission Tomography*